Afya Limited (NASDAQ:AFYA) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Afya Limited (NASDAQ:AFYAGet Free Report) have received a consensus rating of “Hold” from the seven brokerages that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and one has issued a buy recommendation on the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $17.3750.

AFYA has been the topic of several recent research reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Afya in a research note on Wednesday. Sanford C. Bernstein raised shares of Afya to a “market perform” rating in a research note on Friday, January 16th. Zacks Research cut shares of Afya from a “hold” rating to a “strong sell” rating in a research report on Friday, January 9th. UBS Group reissued a “neutral” rating and issued a $16.00 price target (down previously from $18.00) on shares of Afya in a research note on Friday, January 16th. Finally, JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $22.00 price objective (down from $24.50) on shares of Afya in a research note on Wednesday, January 7th.

Check Out Our Latest Stock Analysis on Afya

Afya Trading Up 2.3%

Shares of AFYA opened at $14.65 on Friday. The stock’s fifty day simple moving average is $14.74 and its 200-day simple moving average is $14.91. The firm has a market capitalization of $1.37 billion, a PE ratio of 10.54, a price-to-earnings-growth ratio of 0.54 and a beta of 0.53. Afya has a 12-month low of $13.12 and a 12-month high of $19.90. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 0.21.

Institutional Trading of Afya

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Van ECK Associates Corp boosted its stake in Afya by 15.7% during the 3rd quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock worth $159,000 after acquiring an additional 1,377 shares during the last quarter. Perpetual Ltd raised its holdings in Afya by 1.8% in the second quarter. Perpetual Ltd now owns 151,180 shares of the company’s stock worth $2,700,000 after purchasing an additional 2,730 shares during the period. Arrowstreet Capital Limited Partnership boosted its position in shares of Afya by 5.6% during the second quarter. Arrowstreet Capital Limited Partnership now owns 68,169 shares of the company’s stock worth $1,217,000 after purchasing an additional 3,626 shares in the last quarter. Dodge & Cox grew its holdings in shares of Afya by 12.8% in the 2nd quarter. Dodge & Cox now owns 35,262 shares of the company’s stock valued at $630,000 after buying an additional 4,000 shares during the period. Finally, Militia Capital Partners LP bought a new stake in shares of Afya in the 2nd quarter valued at $71,000. 88.02% of the stock is owned by institutional investors.

Afya Company Profile

(Get Free Report)

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.

Read More

Analyst Recommendations for Afya (NASDAQ:AFYA)

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.